| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d29a918d7ec83cea80d61d1dbc478cf |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-93 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-04 |
| filingDate |
2009-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a51ee384f8628479edf34d7b84fb084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b8f0bfb98b9f8ba697beee6017f05a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18f6be30900b0e8c6cafaf2b599de631
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f97672358cb53dc1bdd0df9d08cdde4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e93cc7654a37c68f5537d34287bf0449
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db4a43947172a7cdc51c7a90e3af0a18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25e867941b087404163db267af83e4f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e869c3aff48b8b495f9f6326dcb19b92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_756fa292c75d7c862cef82fdf767b65c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b14840eaf067af8357d394159922afb |
| publicationDate |
2014-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-101695570-B |
| titleOfInvention |
Univalent and bivalent inactivated vaccine for hand-foot-and-mouth disease and preparation method thereof |
| abstract |
The invention discloses a univalent and bivalent inactivated vaccine for preventing Enterovirus 71 (EV71) and Coxsackie virus A16 (Cox.A16) of hand-foot-and-mouth disease, and a preparation method thereof. The preparation method comprises the following steps: screening vaccine strains for the hand-foot-and-mouth disease; establishing and verifying a vaccine strain third-stage seed lot library; culturing cells; inoculating and propagating virus; collecting virus suspension; inactivating the virus; ultra-filtering, concentrating and purifying the virus suspension to obtain vaccine stock solution; and finally preparing the univalent and bivalent inactivated vaccine. The univalent and bivalent inactivated vaccine has good application prospect for preventing the hand-foot-and-mouth disease. |
| priorityDate |
2009-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |